October 09, 2015
After five years of secret negotiations, representatives from 12 countries came to an agreement on the Trans-Pacific Partnership (TPP) on Monday. If implemented, the deal would allow drug companies to lock in patent protections on critical medications for seniors, making it more difficult to get generics on the market. It could also open drug subsidy programs under Medicare and Medicaid to challenges in secret international tribunals. The Alliance has already begun focusing on plans to stop the TPP, including passing resolutions at the local level; preparing activists for the fight ahead; and educating members on the issue.